Vertex announced that the United Kingdom Medicines and Healthcare products Regulatory Agency has granted approval for ALYFTREK, a once-daily next-in-class triple combination cystic fibrosis ...

Vertex Pharmaceuticals’ (VRTX) non-opioid pain drug Journavx was picked up by UnitedHealth’s (UNH) Optum on “Tier 3.” The insurer said, “Journavx has been placed on Tier 3 of the Optum ...

NBC News' Sahil Kapur caught up with Lando Norris as he looks ahead to competing for the 2025 F1 championship. Norris discussed his strategy for the upcoming season, his favorite parts of ...

Ross Chastain has been one of the most consistent top finishers at Las Vegas Motor Speedway over the past three years and although he hasn't won a race there during that span, the 32-year-old has ...

Copyright © 2025 MarketWatch, Inc. All rights reserved.